Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of abemaciclib (ID 14)

Lecture Time
17:20 - 17:40
Speakers
  • Maria Lallena (Alcobendas, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of palbociclib (ID 12)

Lecture Time
16:40 - 17:00
Speakers
  • Angel Guerrero (Valencia, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Comparison of preclinical data across CDK 4-6 (ID 15)

Lecture Time
17:40 - 18:00
Speakers
  • Romano Danesi (Pisa, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of ribociclib (ID 13)

Lecture Time
17:00 - 17:20
Speakers
  • Gustavo Baldassarre (Aviano, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

Interaction with immune system (ID 21)

Lecture Time
10:20 - 10:40
Speakers
  • Fabrice AndrĂ© (Villejuif, FR)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

PIK3 (ID 19)

Lecture Time
09:40 - 10:00
Speakers
  • Violeta Serra (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

Synthetic lethality (ID 17)

Lecture Time
09:00 - 09:20
Speakers
  • Rene Bernards (Amsterdam, NL)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

Q&A (ID 22)

Lecture Time
10:40 - 10:50
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

MEK (ID 20)

Lecture Time
10:00 - 10:20
Speakers
  • Olivier Michielin (Lausanne, CH)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

RAS/RAF pathway (ID 18)

Lecture Time
09:20 - 09:40
Speakers
  • Federica Di Nicolantonio (Candiolo, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
The disappointing results of initial CDKI and their role in other disease (ID 7) Educational session

Roscovitine (ID 23)

Lecture Time
11:35 - 12:00
Speakers
  • Laurent Meijer (Roscoff, FR)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
The disappointing results of initial CDKI and their role in other disease (ID 7) Educational session

CDKi in non-malignant diseases (ID 27)

Lecture Time
12:00 - 12:25
Speakers
  • Laurent Meijer (Roscoff, FR)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40